Table of Content

Open Access iconOpen Access

ARTICLE

Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases

Nazneen Fatima1, Daniel J. Canter2,3, Bradley C. Carthon4,6, Omer Kucuk4,6, Viraj A. Master5,6, Peter T. Nieh5,6, Kenneth Ogan5,6, Adeboye O. Osunkoya1,5,6

1 Department of Pathology, Emory University School of Medicine, Atlanta, Georgia, USA
2 Department of Urology, Einstein Health Network, Philadelphia, Pennsylvania, USA
3 Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
4 Department of Hematology-Oncology, Emory University School of Medicine, Atlanta, Georgia, USA
5 Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA
6 Emory Winship Cancer Institute, Atlanta, Georgia, USA
Address correspondence to Dr. Adeboye O. Osunkoya, Departments of Pathology and Urology, Emory University School of Medicine, 1364 Clifton Road, NE, Suite H174, Atlanta, GA 30322 USA

Canadian Journal of Urology 2015, 22(3), 7783-7787.

Abstract

Introduction: Sarcomatoid urothelial carcinoma is a dedifferentiated biphasic tumor that exhibits morphological and/or immunohistochemical evidence of epithelial and mesenchymal differentiation. In this series, we analyzed the clinicopathologic features of this rare variant of urothelial carcinoma.
Materials and methods: A search was made through our surgical pathology files and consultation files of the senior author for cases of sarcomatoid urothelial carcinoma of the bladder from 2005-2014. All the slides were retrieved and re-reviewed, and clinical data was also obtained including follow up.
Results: Thirty-seven cases of sarcomatoid urothelial carcinoma of the bladder were identified. Mean patient age was 71 years (range: 51 to 88 years). Twenty-six of 37 (70%) patients were male and 11/37 (30%) patients were female. Twenty-five cases were from cystectomy/cystoprostatectomy specimens, 8 cases from transurethral resection of bladder tumor specimens and 4 cases were from biopsy specimens. The mean tumor size was 5 cm (range: 1.4 cm to 13.0 cm). Four of 37 (10%) cases had focal heterologous components; 1 case with both chondroid and osteoid, 2 cases with chondroid and 1 case rhabdoid elements. Twenty-one of 37 (56%) patients died within a year of presentation.
Conclusions: Sarcomatoid urothelial carcinoma of the bladder is more prevalent in males, with the mean age of 71 years in our series. Smoking is an important risk factor. Sarcomatoid urothelial carcinoma is an aggressive variant of urothelial carcinoma which commonly presents at an advanced stage, and over 50% of patients in our series died of disease within 1 year of presentation.

Keywords

urothelial carcinoma, sarcomatoid differentiation, clinicopathologic analysis, follow up, prognosis

Cite This Article

APA Style
Fatima, N., Canter, D.J., Carthon, B.C., Kucuk, O., Master, V.A. et al. (2015). Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases. Canadian Journal of Urology, 22(3), 7783–7787.
Vancouver Style
Fatima N, Canter DJ, Carthon BC, Kucuk O, Master VA, Nieh PT, et al. Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases. Can J Urology. 2015;22(3):7783–7787.
IEEE Style
N. Fatima et al., “Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases,” Can. J. Urology, vol. 22, no. 3, pp. 7783–7787, 2015.



cc Copyright © 2015 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 156

    View

  • 149

    Download

  • 0

    Like

Share Link